| human | Q5 |
| P496 | ORCID iD | 0000-0002-4253-5930 |
| P1153 | Scopus author ID | 7003430118 |
| P69 | educated at | University of Patras | Q1462246 |
| Medical College of Georgia | Q16973985 | ||
| P108 | employer | Yale University | Q49112 |
| National and Kapodistrian University of Athens | Q547867 | ||
| University of Patras | Q1462246 | ||
| Medical College of Georgia | Q16973985 | ||
| P735 | given name | Andreas | Q4926263 |
| Andreas | Q4926263 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q51522061 | (1)H, (13)C, (15)N backbone and side-chain resonance assignment of Nostoc sp. C139A variant of the heme-nitric oxide/oxygen binding (H-NOX) domain. |
| Q42370620 | A ginseng-derived oestrogen receptor beta (ERbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis |
| Q36025388 | A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization. |
| Q90756722 | A selective and sensitive method for quantification of endogenous polysulfide production in biological samples |
| Q37216894 | ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide. |
| Q71510284 | Aminopeptidase P is disposed on human endothelial cells |
| Q73586047 | Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway |
| Q40644510 | Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production |
| Q80925539 | Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma |
| Q46471401 | Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage |
| Q54330996 | Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa. |
| Q59413414 | Angiopoietin-2 is increased in septic shock: Evidence for the existence of a circulating factor stimulating its release from human monocytes |
| Q42504250 | Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators |
| Q83310488 | Angiopoietin-2 levels are elevated in exudative pleural effusions |
| Q42029292 | Anti-angiogenic properties of a sulindac analogue |
| Q45915926 | Antioxidant supplementation alters cytokine production from monocytes. |
| Q39817893 | Automated angiogenesis quantification through advanced image processing techniques. |
| Q35661834 | Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. |
| Q89575848 | Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase |
| Q90849323 | Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice |
| Q74587563 | Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors |
| Q51598935 | Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. |
| Q57781144 | Cystathionine γ lyase sulfhydrates the RNA binding protein HuR to preserve endothelial cell function and delay atherogenesis |
| Q37353949 | Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach. |
| Q36797373 | D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase |
| Q46712026 | Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents |
| Q41044129 | Dynamic activation of endothelial nitric oxide synthase by Hsp90. |
| Q34145385 | Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro |
| Q40510083 | Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract |
| Q100510788 | Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies |
| Q51440774 | Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning. |
| Q27021649 | Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS |
| Q89805532 | Generation and Characterization of a CRISPR/Cas9 -Induced 3-mst Deficient Zebrafish |
| Q51687813 | Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation. |
| Q71510289 | Human aortic endothelial cell aminopeptidase N |
| Q46286226 | Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection |
| Q34402692 | Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. |
| Q36341617 | Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes |
| Q24597604 | Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation |
| Q42969013 | Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. |
| Q30492603 | Hydrogen sulfide is an endogenous stimulator of angiogenesis. |
| Q35170942 | Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function |
| Q28574416 | Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A |
| Q35375963 | Hydrogen sulphide and angiogenesis: mechanisms and applications. |
| Q36480208 | Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling |
| Q73118384 | Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat |
| Q59413542 | Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice |
| Q40715050 | Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin |
| Q60695400 | Inhibition of Nitric Oxide–Stimulated Vasorelaxation by Carbon Monoxide-Releasing Molecules |
| Q40173368 | Inhibition of endothelial nitric oxide synthase by the lipid phosphatase PTEN. |
| Q27680135 | Insights into Soluble Guanylyl Cyclase Activation Derived from Improved Heme-Mimetics |
| Q28572045 | Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding |
| Q43919941 | Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice |
| Q83421445 | MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress |
| Q104287600 | Mapping the Endothelial Cell S-Sulfhydrome Highlights the Crucial Role of Integrin Sulfhydration in Vascular Function |
| Q40233392 | Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. |
| Q42575759 | Mastic oil inhibits the metastatic phenotype of mouse lung adenocarcinoma cells |
| Q49729993 | Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells. |
| Q34129753 | Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes |
| Q51020622 | Modulation of the release of Ang-2 in experimental endotoxic shock by a species-specific circulating factor. |
| Q34075870 | Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content. |
| Q54485227 | Nitric oxide regulates cytokine induction in the diaphragm in response to inspiratory resistive breathing. |
| Q39758977 | Nitric oxide stimulates interleukin-6 production in skeletal myotubes |
| Q91233657 | Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug |
| Q54472343 | PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection? |
| Q54652077 | PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis. |
| Q44947192 | Perillyl alcohol is an angiogenesis inhibitor. |
| Q43197362 | Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities |
| Q38545038 | Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors |
| Q41879758 | Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents |
| Q40736410 | Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species |
| Q39786074 | Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma |
| Q42439086 | Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity. |
| Q70460107 | Radiation-induced alterations in angiotensin converting enzyme activity in cultured bovine pulmonary arterial endothelial cell monolayers |
| Q37645448 | Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin |
| Q38939480 | Regulation and role of endogenously produced hydrogen sulfide in angiogenesis |
| Q59413538 | Regulation of Ang2 release by PTEN/PI3-kinase/Akt in lung microvascular endothelial cells |
| Q42490189 | Regulation of Ang2 release by PTEN/PI3-kinase/Akt in lung microvascular endothelial cells |
| Q35707083 | Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid. |
| Q22010149 | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt |
| Q93551287 | Regulation of soluble guanylyl cyclase by phosphorylation |
| Q93551376 | Regulation of soluble guanylyl cyclase by phosphorylation |
| Q42361109 | Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide |
| Q36052610 | Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species |
| Q38305532 | Role of cGMP in hydrogen sulfide signaling |
| Q36248991 | Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells. |
| Q38957953 | Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression. |
| Q98618081 | Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors |
| Q63965443 | Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of |
| Q36943270 | Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). |
| Q91411186 | Shear stress regulates cystathionine γ lyase expression to preserve endothelial redox balance and reduce membrane lipid peroxidation |
| Q47321908 | Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress |
| Q46403664 | Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress |
| Q64377535 | Soluble guanylyl cyclase activation promotes angiogenesis |
| Q46201963 | Soluble guanylyl cyclase as a therapeutic target in chronic obstructive pulmonary disease (COPD). |
| Q59413533 | Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury |
| Q46688310 | Soluble guanylyl cyclase expression is reduced in allergic asthma |
| Q35985608 | Soluble guanylyl cyclase: more secrets revealed. |
| Q44810100 | Structural and functional characterization of the dimerization region of soluble guanylyl cyclase |
| Q54186047 | Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents. |
| Q33520860 | Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase |
| Q37109566 | The angiopoietin/Tie2 axis mediates malignant pleural effusion formation |
| Q79568344 | The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway |
| Q90404022 | The protective role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway against experimental osteoarthritis |
| Q26825733 | The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning |
| Q48033453 | The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease |
| Q43209084 | The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability |
| Q60695399 | Thioglycine and l-thiovaline: Biologically active H2S-donors |
| Q40938612 | Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. |
| Q45949492 | Tricyclic indole and dihydroindole derivatives as new inhibitors of soluble guanylate cyclase. |
| Q49100344 | Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2. |
| Q42456094 | Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. |
| Q40320118 | Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. |
| Q42426443 | Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? |
| Q42453685 | Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity |
| Q46943126 | cGMP-dependent and -independent angiogenesis-related properties of nitric oxide |
| Q34535138 | cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. |
| Q37002324 | cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. |
Search more.